Clinical Trials
11 trialsNCT00023725 2013-06-24
Radiation Therapy With or Without SU5416 in Treating Patients With Soft Tissue Sarcoma
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT00023738 2013-06-24
Chemotherapy, SU5416, Radiation Therapy, and Surgery in Treating Patients With Soft Tissue Sarcoma
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT00026260 2013-06-24
SU5416 in Treating Patients With Persistent or Recurrent Cervical Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00006014 2013-06-03
SU5416 in Treating Patients With Malignant Mesothelioma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00005862 2013-02-11
SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas
National Cancer Institute (NCI)
Phase 2 Completed
NCT00017316 2013-02-11
Thalidomide and SU5416 in Treating Patients With Metastatic Melanoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00006000 2013-01-31
SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00005818 2013-01-23
SU5416 and Irinotecan in Treating Patients With Advanced Colorectal Cancer
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT00005942 2013-01-23
Liposomal Daunorubicin and SU5416 in Treating Patients With Hematologic Cancer That Has Not Responded to Initial Therapy
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT00006361 2009-12-04
SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck
National Cancer Institute (NCI)
Phase 2 Completed
NCT00006155 2008-03-04
SU5416 and Carboplatin to Treat Ovarian Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Completed